ArticleMedical oncology (Northwood, London, England)2023

What is the optimal (neo)adjuvant strategy of extremity high-risk soft tissue sarcomas (ESTS)?

Saoussane Kharmoum et al.PubMed ↗Publisher ↗

No numbers read from the abstract.